A functional framework in patient fibroblasts informs ATP7A variant pathogenicity and identifies p.Q990P as a novel cause of distal motor neuropathy
Human Molecular Genetics · 06.06.2026 · 35 (14)
DOI: 10.1093/hmg/ddag061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 08.07.2026. Verfasst von Gonzalo Perez-Siles und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2050, Australia. Hauptthemen laut MEDLINE: Copper-Transporting ATPases, Menkes Kinky Hair Syndrome, Cutis Laxa, Ehlers-Danlos Syndrome. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHMRC Ideas Grant, MLK and GP-S and Medical Research Future Fund, AFM-Telethon.
Abstract (Originalsprache)
ATP7A is a P-type ATPase copper transporter and a central component of the intracellular network to maintain copper (Cu) homeostasis, trafficking between the trans-Golgi network (TGN) and the cell periphery in response to intracellular Cu levels. Pathogenic ATP7A variants cause Menkes disease (MNK), occipital horn syndrome (OHS) and X-linked distal hereditary motor neuropathy (HMNX), with the clinical severity inversely related to residual ATP7A function. In MNK and OHS, variants result in loss of ATP7A function due to absent (MNK) or markedly reduced (OHS) protein levels, leading to abolished ATP7A trafficking and/or impaired Cu transport capacity. HMNX-associated variants are thought to retain partial Cu transport activity, although functional data remain limited. To date, three missense variants (p.T994I, p.P1386S, p.A991D) are established causes of HMNX, but the number of ATP7A variants reported in patients with a distal motor neuropathy phenotype is increasing, creating a need for functional assessment of variants of uncertain significance (VUS). We have developed a functional framework for evaluating HMNX-associated ATP7A variants. Using three patient fibroblast lines carrying the confirmed variants, we demonstrate reduced ATP7A TGN localization under low-Cu conditions and impaired capacity of these cell lines to maintain intracellular Cu levels. By applying these assays to five VUS (p.R703H, p.Y760C, p.A768G, p.Q990P, p.M1311V) identified in individuals from unsolved peripheral neuropathy families, we identify p.Q990P as a novel ATP7A variant in a patient with progressive peripheral motor neuropathy. This approach enables comparison of Cu trafficking and handling across ATP7A alleles, providing a functional framework to support diagnostic variant classification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2050, Australia.
- Northcott Neuroscience Laboratory, ANZAC Research Institute, Gate 3 Hospital Road, Sydney Local Health District, Sydney, NSW 2139, Australia.
- Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, Antwerp 2610, Belgium.
- Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, Antwerp 2610, Belgium.
- Neuromuscular Reference Centre, Department of Neurology, Antwerp University Hospital, Drie Eikenstraat 655, Antwerp 2650, Belgium.
- West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women's and Children's Hospitals NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham B15 2TG, United Kingdom.
ORCID-Profile: Rita Horvath, Kleopas A Kleopa, Marina L Kennerson
Förderung
- NHMRC Ideas Grant
- MLK and GP-S and Medical Research Future Fund
- AFM-Telethon
- Ataxia UK
- Hereditary Neuropathy Foundation
- LifeArc Centre to Treat Mitochondrial Diseases
- UKRI/Horizon Europe Guarantee MSCA Doctoral Network Programme
- Medical Research Council
Zitieren
APA
Perez-Siles, G., Grosz, B. R., Ellis, M., Baets, J., Sabir, A., O'Driscoll, M., Horvath, R., Kleopa, K. A., La Fontaine, S., Gourdon, P., Vucic, S., & Kennerson, M. L. (2026). A functional framework in patient fibroblasts informs ATP7A variant pathogenicity and identifies p.Q990P as a novel cause of distal motor neuropathy. Human Molecular Genetics, 35(14). https://doi.org/10.1093/hmg/ddag061
Vancouver
Perez-Siles G, Grosz BR, Ellis M, Baets J, Sabir A, O'Driscoll M, et al. A functional framework in patient fibroblasts informs ATP7A variant pathogenicity and identifies p.Q990P as a novel cause of distal motor neuropathy. Human Molecular Genetics. 2026;35(14). doi:10.1093/hmg/ddag061
BibTeX
@article{PerezSiles2026,
author = {Perez-Siles, Gonzalo and Grosz, Bianca R and Ellis, Melina and Baets, Jonathan and Sabir, Ataf and O'Driscoll, Mary and Horvath, Rita and Kleopa, Kleopas A and La Fontaine, Sharon and Gourdon, Pontus and Vucic, Steve and Kennerson, Marina L},
title = {A functional framework in patient fibroblasts informs ATP7A variant pathogenicity and identifies p.Q990P as a novel cause of distal motor neuropathy},
journal = {Human Molecular Genetics},
year = {2026},
volume = {35},
number = {14},
doi = {10.1093/hmg/ddag061}
}
EUVIMED